A Comparative Effect of Echogenic Needle for Nerve Block on Acute and Chronic Postoperative Pain

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Chronic Postoperative Pain
Interventions
PROCEDURE

Echogenic nerve block needle

A 22G 8-cm echogenic nerve block needle (LEAPMED, CHINA) is selected for the procedure, administered under ultrasound guidance. Subsequently, a volume of 20 ml 0.375% ropivacaine is injected at the needle's tip for analgesic effect. The spread of the medication will be assessed through short- and long-axis imaging perspectives. Following this, evaluations are conducted to assess acute postoperative pain as well as chronic postoperative pain. Parameters such as the duration of nerve blockade, the incidence of punctures, and any associated complications are all meticulously appraised.

PROCEDURE

Non-echogenic nerve block needle

A 22G 8-cm thin wall low bottom nerve block needle (KDL, CHINA) is selected for the procedure, administered under ultrasound guidance. Subsequently, a volume of 20 ml 0.375% ropivacaine is injected at the needle's tip for analgesic effect. The distribution of the medication will be assessed using short- and long-axis imaging perspectives. Following this, evaluations are conducted to assess acute postoperative pain as well as chronic postoperative pain. Parameters such as the duration of nerve blockade, the number of punctures, and any associated complications are all meticulously appraised.

Trial Locations (1)

4000000

RECRUITING

He Huang, Chongqing

All Listed Sponsors
lead

The Second Affiliated Hospital of Chongqing Medical University

OTHER